ADGM Adagio Medical Holdings, Inc - Common Stock
$0,86
Prix · Mai 20, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$1–$3
7% of range
Note des analystes
BUY
8 analysts
Objectif de cours
$4
+307% upside
P/E (TTM)
-0.7
ROE
-238.1%
Marge nette
—
ADGM Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.86
Capitalisation Boursière
$23M
P/E (TTM)
-0.7
BPA (TTM)
$-1.51
Revenus (TTM)
$0
Rendement div.
—
ROE
-238.1%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $3
ADGM Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2023-12-31
→
2025-12-31
BPA
$-1.51
2023-12-31
→
2025-12-31
Flux de trésorerie libre
$-19M
2025-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ADGM
Médiane des pairs
P/E (TTM)
-0.7
73.1
P/B
1.9
3.4
Price / FCF (Cours / FCF)
-1.2
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ADGM
Médiane des pairs
ROA
-54.7%
-86.2%
ROE
-238.1%
-161.3%
ROIC
-176.5%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ADGM
Médiane des pairs
Current Ratio (Ratio de liquidité)
2.4
3.0
Quick Ratio (Ratio de liquidité réduite)
2.1
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ADGM
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ADGM
Médiane des pairs
ADGM Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
8 analystes
- Achat fort 2 25,0%
- Achat 5 62,5%
- Conserver 1 12,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
2 analystes · 2026-05-16
Médiane
$3.50
← En dessous de tous les objectifs
$0.86
Bas
$3.00
Haut
$4.00
Objectif médian
$3.50
+307,0%
Objectif moyen
$3.50
+307,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.07%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.31 | $-0.30 | -0.01% |
| 31 décembre 2025 | $-0.16 | $-0.32 | 0.16% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ADGM | $23M | -0.7 | — | — | -238.1% | — |
| CTSO | — | -4.9 | 4.1% | — | — | — |
| FEMY | $34M | -1.2 | 40.8% | -812.3% | -505.0% | — |
| MODD | $59M | -2.1 | — | — | -137.7% | — |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| ICU | — | — | — | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | · | $300.0K | |
| Cost of Revenue | $684.0K | · | $1M | |
| R&D Expense | $11M | · | $15M | |
| SG&A Expense | $11M | · | $12M | |
| Operating Expenses | $22M | · | $28M | |
| Operating Income | $-22M | · | $-28M | |
| Interest Income | $477.0K | · | $3.0K | |
| Other Non-op | $195.0K | · | $-20.0K | |
| Pretax Income | $-25M | · | $-37M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-25M | · | $-37M | |
| EPS (Basic) | $-1.51 | · | $-48.16 | |
| EPS (Diluted) | $-1.51 | · | $-48.16 | |
| Shares (Basic) | 16,577,126 | · | 759,814 | |
| Shares (Diluted) | 16,577,126 | · | · | |
| EBITDA | $-21M | · | · |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $17M | $21M | $1M | |
| Receivables | · | $35.0K | $71.0K | |
| Inventory | $2M | $3M | $3M | |
| Prepaid Expense | $989.0K | $2M | $232.0K | |
| Other Current Assets | $316.0K | $222.0K | $177.0K | |
| Current Assets | $20M | $25M | $5M | |
| PP&E (Net) | $2M | $2M | $1M | |
| PP&E (Gross) | $4M | $5M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Goodwill | $14M | $14M | $0 | |
| Intangibles | $7M | $7M | $0 | |
| Other Non-current Assets | $3.0K | $14.0K | $23.0K | |
| Total Assets | $43M | $48M | $7M | |
| Accounts Payable | $1M | $3M | $4M | |
| Accrued Liabilities | $7M | $4M | $3M | |
| Current Liabilities | $8M | $8M | $47M | |
| Capital Leases | $563.0K | $46.0K | $52.0K | |
| Deferred Tax | $883.0K | $883.0K | · | |
| Other Non-current Liabilities | · | $4M | $8.0K | |
| Total Liabilities | $31M | $29M | $47M | |
| Long-term Debt | $21M | $17M | $38M | |
| Common Stock | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $108M | $90M | $2M | |
| Retained Earnings | $-96M | $-71M | $-134M | |
| AOCI | $-99.0K | $1.0K | $17.0K | |
| Stockholders' Equity | $12M | $20M | $-132M | |
| Liabilities + Equity | $43M | $48M | $7M | |
| Shares Outstanding | 22,210,459 | 15,198,232 | 779,908 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $970.0K | · | $532.0K | |
| Stock-based Comp | $1M | · | $442.0K | |
| Amort. of Intangibles | $0 | · | · | |
| Other Non-cash | $4M | · | · | |
| Operating Cash Flow | $-19M | · | $-26M | |
| CapEx | $374.0K | · | $333.0K | |
| Investing Cash Flow | $-374.0K | · | $-340.0K | |
| Stock Issued | $16M | · | · | |
| Net Stock Activity | $16M | · | · | |
| Financing Cash Flow | $16M | · | $22M | |
| Net Change in Cash | $-3M | · | $-4M | |
| Free Cash Flow | $-19M | · | · |
Rentabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -54.7% | · | · | |
| ROE | -238.1% | · | · | |
| ROIC | -176.5% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | · | · | |
| Quick Ratio | 2.1 | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | |
| Inventory Turnover | 0.3 | · | · |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $453.0K | · | |
| Net Income TTM | $-25M | $-21M | · | |
| Market Cap | $23M | · | · | |
| P/E | -0.7 | -0.0 | · | |
| P/B | 1.9 | · | · | |
| P / Cash Flow | -1.2 | · | · | |
| P / FCF | -1.2 | · | · | |
| Earnings Yield | -145.2% | -3024.8% | · |
Compte de résultat 14
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | · | $0 | · | $132.0K | $254.0K | $26.0K | $78.0K | |
| Cost of Revenue | · | $58.0K | $31.0K | $342.0K | $253.0K | · | $414.0K | $682.0K | $542.0K | $334.0K | |
| R&D Expense | $3M | $2M | $3M | $2M | $4M | · | $1M | $3M | $3M | $2M | |
| SG&A Expense | $2M | $2M | $3M | $2M | $3M | · | $3M | $3M | $5M | $3M | |
| Operating Expenses | $5M | $4M | $6M | $5M | $7M | · | $5M | $7M | $9M | $5M | |
| Operating Income | $-5M | $-4M | $-6M | $-5M | $-7M | · | $-4M | $-7M | $-9M | $-5M | |
| Interest Income | $107.0K | $132.0K | $79.0K | $102.0K | $164.0K | · | $166.0K | $2.0K | $1.0K | $1.0K | |
| Other Non-op | $70.0K | $127.0K | $12.0K | $102.0K | $-46.0K | · | $72.0K | $5.0K | $-43.0K | $93.0K | |
| Net Income | $-7M | $-3M | $-10M | $-4M | $-8M | · | $4M | $-6M | $-8M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.09 | $-0.66 | $-0.26 | $-0.50 | · | $0.18 | $-7.35 | $-10.28 | $-11.33 | |
| EPS (Diluted) | $-0.31 | $0.01 | $-0.66 | $-0.35 | $-0.51 | · | $0.02 | $-7.35 | $-10.28 | $-11.33 | |
| Shares (Basic) | 22,210,459 | -29,561,525 | 15,381,565 | 15,381,565 | 15,375,521 | · | 14,057,636 | 779,908 | 779,908 | 325 | |
| Shares (Diluted) | 22,210,459 | -29,561,525 | 15,381,565 | 15,381,565 | 15,375,521 | · | 16,057,636 | 779,908 | · | · | |
| EBITDA | $-5M | · | $-6M | $-5M | $-7M | · | $-4M | · | · | · |
Bilan 28
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $5M | $8M | $13M | $21M | $28M | · | · | $1M | |
| Receivables | · | · | · | · | $1.0K | $35.0K | $90.0K | · | · | $71.0K | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $3M | $4M | · | · | $3M | |
| Prepaid Expense | $1M | $989.0K | $1M | $1M | $2M | $2M | $2M | · | · | $232.0K | |
| Other Current Assets | $281.0K | $316.0K | $811.0K | $1M | $507.0K | $222.0K | $213.0K | · | · | $177.0K | |
| Current Assets | $16M | $20M | $8M | $12M | $17M | $25M | $35M | · | · | $5M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | $1M | |
| PP&E (Gross) | $4M | $4M | $4M | $5M | $5M | $5M | $4M | · | · | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $3M | $3M | $3M | $3M | · | · | $2M | |
| Goodwill | $14M | $14M | $14M | $14M | $14M | $14M | $44M | · | · | $0 | |
| Intangibles | $7M | $7M | $7M | $7M | $7M | $7M | $26M | · | · | $0 | |
| Other Non-current Assets | $1.0K | $3.0K | $6.0K | $9.0K | $11.0K | $14.0K | $16.0K | · | · | $23.0K | |
| Total Assets | $39M | $43M | $32M | $36M | $41M | $48M | $107M | · | · | $7M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $3M | $3M | $4M | · | · | $4M | |
| Accrued Liabilities | $7M | $7M | $8M | $3M | $3M | $4M | $3M | · | · | $3M | |
| Current Liabilities | $9M | $8M | $10M | $5M | $6M | $8M | $8M | · | · | $47M | |
| Capital Leases | $992.0K | $563.0K | $596.0K | $629.0K | $668.0K | $46.0K | $85.0K | · | · | $52.0K | |
| Deferred Tax | $883.0K | $883.0K | $883.0K | $883.0K | $883.0K | $883.0K | $3M | · | · | · | |
| Other Non-current Liabilities | · | · | · | $4M | $4M | $4M | $4M | · | · | $8.0K | |
| Total Liabilities | $34M | $31M | $33M | $27M | $29M | $29M | $31M | $5.0K | · | $47M | |
| Long-term Debt | $23M | $21M | $21M | $17M | $18M | $17M | $14M | · | · | $38M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | · | · | $1.0K | |
| Paid-in Capital | $108M | $108M | $91M | $91M | $91M | $90M | $90M | $2M | · | $2M | |
| Retained Earnings | $-103M | $-96M | $-92M | $-82M | $-78M | $-71M | $-13M | $-2M | · | $-134M | |
| AOCI | $-143.0K | $-99.0K | $-95.0K | $-99.0K | $-60.0K | $1.0K | $-9.0K | · | · | $17.0K | |
| Stockholders' Equity | $6M | $12M | $-1M | $9M | $12M | $20M | $77M | $-5.0K | · | $-132M | |
| Liabilities + Equity | $39M | $43M | $32M | $36M | $41M | $48M | $107M | · | · | $7M | |
| Shares Outstanding | 22,210,459 | 22,210,459 | 15,381,565 | 15,381,565 | 15,381,565 | 15,198,232 | 14,535,136 | · | · | 779,908 |
Flux de trésorerie 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $210.0K | $237.0K | $191.0K | $271.0K | $271.0K | · | $316.0K | $257.0K | $330.0K | $133.0K | |
| Stock-based Comp | $389.0K | $890.0K | $137.0K | $234.0K | $218.0K | · | · | $111.0K | $110.0K | $113.0K | |
| Amort. of Intangibles | · | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Other Non-cash | $2M | · | · | · | $13.0K | · | $-10M | · | · | · | |
| Operating Cash Flow | $-4M | $-4M | $-3M | $-5M | $-7M | · | $-6M | $-7M | $-7M | $-7M | |
| CapEx | $2.0K | $-491.0K | $520.0K | $10.0K | $335.0K | · | $578.0K | $175.0K | $162.0K | $20.0K | |
| Investing Cash Flow | $-2.0K | $491.0K | $-520.0K | $-10.0K | $-335.0K | · | $-578.0K | $-175.0K | $-162.0K | $-20.0K | |
| Financing Cash Flow | · | · | · | · | · | · | · | $5M | $10M | $7M | |
| Net Change in Cash | $-4M | $12M | $-4M | $-5M | $-8M | · | $-7M | $-2M | $3M | $-598.0K | |
| Free Cash Flow | $-4M | · | · | · | $-8M | · | $-7M | · | · | · |
Rentabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -3352.3% | · | · | · | |
| Net Margin | · | · | · | · | · | · | 2731.8% | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | -3112.9% | · | · | · | |
| ROA | -17.3% | · | -14.6% | -22.0% | -37.3% | · | 6.7% | · | · | · | |
| ROE | -77.2% | · | -26.9% | -91.1% | -124.4% | · | 9.4% | 28551.8% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | · | 0.8 | 2.5 | 2.9 | · | 4.4 | · | · | · | |
| Quick Ratio | 1.5 | · | 0.5 | 1.7 | 2.2 | · | 3.6 | · | · | · |
Efficacité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | · | · | 0.0 | · | · | · | |
| Inventory Turnover | · | · | 0.0 | 0.4 | 0.2 | · | 0.2 | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | 2.9 | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $453.0K | $453.0K | · | $453.0K | · | · | · | |
| Net Income TTM | $-29M | · | $-18M | $-14M | $-18M | · | $-21M | · | · | · | |
| Market Cap | $26M | · | $30M | $20M | $12M | · | $38M | · | · | · | |
| P/E | -0.6 | · | -1.3 | -0.2 | -0.0 | · | -0.1 | · | · | · | |
| P/S | · | · | · | 44.1 | 27.3 | · | 82.8 | · | · | · | |
| P/B | 4.5 | · | -22.7 | 2.3 | 1.0 | · | 0.5 | · | · | · | |
| P / Tangible Book | · | · | · | · | · | · | 6.0 | · | · | · | |
| P / Cash Flow | -6.2 | · | · | · | -1.7 | · | -5.9 | · | · | · | |
| P / FCF | -6.2 | · | · | · | -1.6 | · | -5.4 | · | · | · | |
| Earnings Yield | -159.1% | · | -77.3% | -630.0% | -2250.9% | · | -1231.0% | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenu | $0 | — | $300.0K |
| Résultat net | $-25M | — | $-37M |
| BPA dilué | $-1.51 | — | $-48.16 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio de liquidité | 2.4 | — | — |
| Ratio de liquidité réduite | 2.1 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flux de trésorerie libre | $-19M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.